JP2016513738A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513738A5
JP2016513738A5 JP2016502913A JP2016502913A JP2016513738A5 JP 2016513738 A5 JP2016513738 A5 JP 2016513738A5 JP 2016502913 A JP2016502913 A JP 2016502913A JP 2016502913 A JP2016502913 A JP 2016502913A JP 2016513738 A5 JP2016513738 A5 JP 2016513738A5
Authority
JP
Japan
Prior art keywords
composition
effective dose
polyethylene glycol
item
daltons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502913A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513738A (ja
JP6275239B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/028832 external-priority patent/WO2014144425A1/en
Publication of JP2016513738A publication Critical patent/JP2016513738A/ja
Publication of JP2016513738A5 publication Critical patent/JP2016513738A5/ja
Application granted granted Critical
Publication of JP6275239B2 publication Critical patent/JP6275239B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502913A 2013-03-15 2014-03-14 Hmwpegによる骨粗鬆症の管理 Active JP6275239B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798481P 2013-03-15 2013-03-15
US61/798,481 2013-03-15
PCT/US2014/028832 WO2014144425A1 (en) 2013-03-15 2014-03-14 Managing osteoporosis with hmw peg

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017024048A Division JP2017082009A (ja) 2013-03-15 2017-02-13 Hmw pegによる骨粗鬆症の管理

Publications (3)

Publication Number Publication Date
JP2016513738A JP2016513738A (ja) 2016-05-16
JP2016513738A5 true JP2016513738A5 (enExample) 2017-03-16
JP6275239B2 JP6275239B2 (ja) 2018-02-07

Family

ID=51537706

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016502913A Active JP6275239B2 (ja) 2013-03-15 2014-03-14 Hmwpegによる骨粗鬆症の管理
JP2017024048A Withdrawn JP2017082009A (ja) 2013-03-15 2017-02-13 Hmw pegによる骨粗鬆症の管理
JP2018142353A Active JP6619849B2 (ja) 2013-03-15 2018-07-30 Hmw pegによる骨粗鬆症の管理

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017024048A Withdrawn JP2017082009A (ja) 2013-03-15 2017-02-13 Hmw pegによる骨粗鬆症の管理
JP2018142353A Active JP6619849B2 (ja) 2013-03-15 2018-07-30 Hmw pegによる骨粗鬆症の管理

Country Status (11)

Country Link
US (2) US10045949B2 (enExample)
EP (1) EP2968159B1 (enExample)
JP (3) JP6275239B2 (enExample)
AU (2) AU2014229082C1 (enExample)
CY (1) CY1122568T1 (enExample)
DK (1) DK2968159T3 (enExample)
ES (1) ES2744828T3 (enExample)
HU (1) HUE045032T2 (enExample)
PL (1) PL2968159T3 (enExample)
PT (1) PT2968159T (enExample)
WO (1) WO2014144425A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111419823B (zh) * 2020-04-30 2022-03-29 上海公谊药业有限公司 一种延胡索酸泰妙菌素肠溶微丸及其制备方法和用途
NL1044084B1 (nl) 2021-07-05 2023-01-11 Evers Agro B V Mestinjecteur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10338646A (ja) * 1996-08-26 1998-12-22 Takeda Chem Ind Ltd 骨形成促進医薬組成物
US20060198817A1 (en) 2002-11-26 2006-09-07 Alverdy John C Materials and methods for preventing and treating microbe-mediated epithelial disorders
JPWO2004105825A1 (ja) * 2003-01-10 2006-07-20 多木化学株式会社 骨形成用生体材料、該材料を含む注入用製剤、及び該材料を調製するためのキット、並びにこれらを用いる骨形成方法
AU2005323502A1 (en) 2004-04-20 2006-07-13 The University Of Chicago Therapeutic delivery system comprising a high molecular weight PEG-like compound
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) * 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
MX2011009988A (es) * 2009-03-23 2011-11-18 Univ Chicago Metodos para la prevencion y el tratamiento de trastornos epiteliales inducidos por radiaciones.
EP2468265A3 (en) * 2010-12-04 2013-01-02 DEEF Pharmaceutical Industries Co. Homogeneous preparations containing vitamin D

Similar Documents

Publication Publication Date Title
Hedegaard et al. Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems
JP2019524877A5 (enExample)
BR112015028692A8 (pt) agente preventivo ou terapêutico para mastite de animal ruminante
ZA201904591B (en) Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs
JP2009538344A5 (enExample)
JP2016513738A5 (enExample)
MX2020012468A (es) Uso de un bolo oral en el secado de ganado lechero.
PH12020552130A1 (en) Vaccination against porcine circoviruses
JP2019529482A5 (enExample)
JP2018043942A5 (enExample)
Du Pisanie Scabby mouth: dangerous for man and animal
Malik et al. Mass vaccination programs reduce the antimicrobial use and help in controlling antimicrobial resistance
Schoombee Take control of biosecurity challenges
BR112014016575A8 (pt) método para o tratamento da doença de lyme
Dzhavadov Strong Immunity as a Must for Healthy Birds
Mingaleev et al. Application of the New Tuberculostatics-Linarol to Prevent Tuberculosis of Young Cattle under Farm
RU2015126219A (ru) Способ снижения содержания тяжелых металлов в молоке коров
Denisenko et al. Metabolic diseases of highly productive cows
Rybarczyk et al. Lactoferrin as a new treatment approach of E. coli O157: H7 infected ruminants.
Rybarczyk et al. Clearance of Escherichia coli O157: H7 infection in calves by rectal administration of bovine lactoferrin.
Singh et al. Deworming and its Clinical importance in Calf health management
Hoorfar Is it possible to reduce foodborne Campylobacter infections in humans through vaccination of animals?
RU2012133421A (ru) Способ лечения и профилактики псевдомоноза сельскохозяйственных животных
Frondelius et al. Effect of cow factors and daily walking distance on commonly used lameness indicators
Bruner Field experience with Rotavirus type C and Clostridium spp.